GSK Director Wendy Becker Named Board Chair of Sony Group Corporation

GSK announced a significant board-level change at one of its Non-Executive Directors' external commitments.

Rhea-AI Filing Summary

GSK announced a significant board-level change at one of its Non-Executive Directors' external commitments. Wendy Becker, who serves as GSK's Non-Executive Director and Chair of the Remuneration Committee, has been appointed as Chair of the Board of Sony Group Corporation, effective June 24, 2025. This represents a promotion from her previous position as Vice Chair of Sony's Board.

This disclosure, filed as a Form 6-K (foreign issuer report), reflects GSK's commitment to transparency regarding its directors' external appointments and potential commitments. The appointment was officially documented by Victoria Whyte, GSK's Company Secretary.

• Filing Date: June 28, 2025
• Effective Date of Appointment: June 24, 2025
• Key Personnel: Wendy Becker (Non-Executive Director)
• New Role: Chair of Sony Group Corporation Board
• Previous Role at Sony: Vice Chair of the Board

FAQ

Who is GSK's new Sony Board Chair and what was her role at GSK?

Wendy Becker, who serves as GSK's Non-Executive Director and Chair of the Remuneration Committee, was appointed as Chair of the Board of Sony Group Corporation effective June 24, 2025. She previously held the position of Vice Chair of the Board at Sony.

When did GSK announce the board member appointment at Sony Corporation?

GSK announced the appointment through a Form 6-K filed on June 28, 2025, with the actual appointment taking effect on June 24, 2025.

What positions does Wendy Becker hold at GSK plc?

At GSK plc, Wendy Becker serves as a Non-Executive Director and holds the position of Chair of the Remuneration Committee.

Who signed the GSK Form 6-K for the Sony board appointment announcement?

The Form 6-K was signed by Victoria Whyte, who serves as the Company Secretary of GSK plc and is the Authorised Signatory for and on behalf of GSK plc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/24/2025 - 10:09 AM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of June 2025

Commission File Number 001-15170

GSK plc

(Translation of registrant's name into English)

79 New Oxford Street, London, WC1A 1DG

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F . . . .X. . . . Form 40-F . . . . . . . .

GSK plc

Director Declaration

The Company announces that Wendy Becker, Non-Executive Director and Chair of the Remuneration Committee, was appointed Chair of the Board of Sony Group Corporation (Sony) with effect from 24 June 2025. Prior to this appointment, Wendy was Vice Chair of the Board of Sony.

V A Whyte

Company Secretary

24 June 2025

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

GSK plc

(Registrant)

Date: June 24, 2025

By:/s/ VICTORIA WHYTE

--------------------------

Victoria Whyte

Authorised Signatory for and on

behalf of GSK plc